VanEck Medical Robotics and Bionic Engineering UCITS ETF
UCTCYBO
Tracks: MVIS® Global Bionic Healthcare ESG Index (MVBIONTR)
AUM
USD 13M
nano
TER
0.55%
Currency
USD
Replication
Physical
Inception
2022-12-02
Dividend
Accumulating
Domicile
Ireland
Asset Class
—
Classification
Equity Details
As the global population ages, so does the demand for biologically-inspired systems that improve the quality of later life. VanEck’s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue. Invest in companies at the forefront of improving quality of life for the world’s ageing population Gain diversified exposure to companies involved in medical implants and bionic enhancements for chronic diseases and functional impairments Access companies earning at least half their revenues from bionic engineering-related industries Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco Risk: You may lose money up to the total loss of your investment due to the Main Risk Factors such as Equity Market Risk and Industry Concentration Risk described below in the KIID and in the sales prospectus. Outperformance not guaranteed.
Annual Returns
| Year | Annual |
|---|---|
| 2025 | +1.36% |
| 2024 | -0.86% |
| 2023 | +4.60% |